Results 121 to 130 of about 22,921 (208)

Efficacy of azacitidine and trametinib against leptomeningeal melanosis associated with congenital melanocytic nevus syndrome. [PDF]

Mol Cell Pediatr
Raljević L, Komlosi K, Feige U, Eckenweiler M, Lassmann S, Jrad HBH, Werner M, Fischer J, Has C, Feuchtinger T, Uhl M, Niemeyer CM, Hettmer S.   +12 more
europepmc   +1 more source

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia. [PDF]

Blood Neoplasia
Westra N, Cerro ER, Schilder E, Lub-de Hooge MN, Touw DJ, Kosterink JGW, Chitu DA, Ammatuna E, Klein SK, Westerweel PE, Cuijpers M, Cruijsen M, Corsten MMF, Alhan C, Tick L, Schuringa JJ, Huls G, Woolthuis CM, Oude Munnink TH.   +18 more
europepmc   +1 more source

Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers. [PDF]

EJC Suppl
Bridgewater J, Tabatabai G, Macarulla T, Stacchiotti S.   +3 more
europepmc   +1 more source

Venetoclax as a trigger for autoimmune hemolytic anemia in secondary acute myeloid leukemia: A case report. [PDF]

SAGE Open Med Case Rep
Benallaoua K, Lacoeuilhe P, Gendrot B, Muhammad S, Fouquet G.   +4 more
europepmc   +1 more source

Acute Myeloid Leukemia in the Elderly Patient: New Strategies [PDF]

, 2015

core   +1 more source

Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. [PDF]

Oncologist
Safyan RA, White RA, Gonda TA, Lee SM, Han J, Kuriakose N, Yamamoto NK, Kugel S, Jamison JK, Manji GA, Schwartz GJ, Oberstein PE, Bates SE.   +12 more
europepmc   +1 more source

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. [PDF]

J Pers Med
Ko KH, Gelfer R, Wheat JC, Cai SF.
europepmc   +1 more source

Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm. [PDF]

Cancer
Perrone S, De Fazio L, Monachetti S, Molica M.   +3 more
europepmc   +1 more source

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. [PDF]

Blood Adv
Sekeres MA, Mattison R, Artz A, Baer MR, Chua CC, Demichelis-Gómez R, Egan PC, Fletcher L, Foucar C, Garcia JS, Gilberto L, Gómez de León A, Lancet J, Loh KP, Malcovati L, Marini B, Platzbecker U, Sorror ML, Tinsley-Vance S, Treitz J, Oliveros MJ, Ibrahim S, Roldan Y, Guyatt G, Brignardello-Petersen R.   +24 more
europepmc   +1 more source

Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid. [PDF]

Int J Mol Sci
Harrer DC, Lüke F, Pukrop T, Reichle A, Heudobler D.   +4 more
europepmc   +1 more source